abacavir/lamivudine gh 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack
lupin australia pty limited - abacavir hydrochloride monohydrate,lamivudine -
abacavir and lamivudine tablet, film coated
zydus lifesciences limited - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs), lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95) - abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection. abacavir and lamivudine is contraindicated in patients: - who have the hla-b*5701 allele [see warnings and precautions (5.1)] . - with prior hypersensitivity reaction to abacavir [see warnings and precautions (5.1)] or lamivudine. - with moderate or severe hepatic impairment [see use in specific populations (8.7)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abacavir and lamivudine during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary available data from the apr show no difference in the overall risk of birth defects for abacavir or lamivudine compared with the background rate for birth defects of 2.7% in the metropolitan atlanta congenital
abacavir and lamivudine tablet, film coated
zydus pharmaceuticals usa inc. - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs), lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95) - abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection. abacavir and lamivudine is contraindicated in patients: - who have the hla-b*5701 allele [see warnings and precautions (5.1)] . - with prior hypersensitivity reaction to abacavir [see warnings and precautions (5.1)] or lamivudine. - with moderate or severe hepatic impairment [see use in specific populations (8.7)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abacavir and lamivudine during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary available data from the apr show no difference in the overall risk of birth defects for abacavir or lamivudine compared with the background rate for birth defects of 2.7% in the metropolitan atlanta congenital
abacavir sandoz 300 mg film-coat. tabl.
sandoz sa-nv - abacavir 300 mg - film-coated tablet - 300 mg - abacavir 300 mg - abacavir
abacavir and lamivudine tablets usp 600 mg/300 mg film-coated tablet
abacavir and lamivudine - film-coated tablet - abacavir 600 mg lamivudine 300 mg - antivirals for systemic use:
abacavir sulfate and lamivudine tablets 60mg/30mg
mylan laboratories limited c/o surgilinks ltd mylan laboratories limited r&d center plot no. - abacavir sulfate usp lamivudine usp - tablet - abacavir sulfate usp eq. to abacavir 60mg - antivirals for systemic use: combinations of
abacavir sulfate and lamivudine tablets for oral dispersible tablet
cipla ltd cipla house, peninsula business park, ganpatrao - abacavir sulfate usp and lamivudine usp - dispersible tablet - abacavir sulfate usp equivalent to abacavir – 60 - antivirals for systemic use:
abacavir sulfate oral solution usp 20mg/ml
aurobindo pharma limited plot no. 11, survey 9, hitech city, hyderabad - abacavir sulfate usp - oral solution - abacavir sulfate 20 mg/ml - antivirals for systemic use:
abacavir sulfate/lamivudine/zidovudine tablets modified-release tablet
mylan laboratories limited c/o surgilinks ltd mylan laboratories limited r&d centre plot no. - abacavir sulfate usp lamivudine usp zidovudine usp - modified-release tablet - abacavir sulfate usp equivalent to abacavir 300mg - antivirals for systemic use: combinations of
abacavir tablets usp 300
cipla limited cipla house, peninsula business park, ganpatrao - abacavir tablets usp 300 - tablet - abacavir sulphate usp equivalent to abacavir 300mg - antivirals for systemic use: